Publications by authors named "Anna Hecht"

Claim this Profile
L
LNK/ as a novel driver in juvenile myelomonocytic leukemia.
Astrid Wintering, Anna Hecht, Julia Meyer, Eric B Wong, Juwita Hübner

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
Alexander Streuer, Johann-Christoph Jann, Tobias Boch, Maximilian Mossner, Vladimir Riabov, Anna Hecht

Ann Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes.
Eva Altrock, Carla Sens-Albert, Johann-Christoph Jann, Johanna Flach, Vladimir Riabov, Anna Hecht

Exp Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The insertion site is the main risk factor for central venous catheter-related complications in patients with hematologic malignancies.
Daniela Heidenreich, Eleonore Hansen, Sebastian Kreil, Florian Nolte, Mohamad Jawhar, Anna Hecht

Am J Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.
Anna Hecht, Julia A Meyer, Astrid Behnert, Eric Wong, Farid Chehab

Haematologica· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Adult Height by Machine Learning Technique.
Michael Shmoish, Alina German, Nurit Devir, Anna Hecht, Gary Butler

J Clin Endocrinol Metab· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
Anna Hecht, Julia A Meyer, Johann-Christoph Jann, Katja Sockel, Aristoteles Giagounidis

Ann Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events.
Johann-Christoph Jann, Alexander Streuer, Anna Hecht, Florian Nolte, Verena Nowak

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing.
Alexander K Chao, Julia A Meyer, Alex G Lee, Anna Hecht, Theodore Tarver

Leukemia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
Anna Hecht, Julia Meyer, Farid F Chehab, Kristie L White, Kevin Magruder

Pediatr Blood Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Eva Lengfelder, Dennis Görlich, Daniel Nowak, Karsten Spiekermann, Claudia Haferlach, Anna Hecht

Eur J Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
Anna Hecht, Seraphina Doll, Heidi Altmann, Daniel Nowak, Eva Lengfelder

Clin Lymphoma Myeloma Leuk· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Very Severe Differentiation Syndrome in Low Risk Acute Promyelocytic Leukemia - A Peril of Differentiating Therapy].
Anna Hecht, Joerg Mezger, Martina Gnadler, Eva Lengfelder

Dtsch Med Wochenschr· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic importance of expression of the Wilms' tumor 1 gene in newly diagnosed acute promyelocytic leukemia.
Anna Hecht, Florian Nolte, Daniel Nowak, Verena Nowak, Mark Reinwald

Leuk Lymphoma· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia.
Anna Hecht, Daniel Nowak, Verena Nowak, Benjamin Hanfstein, Thomas Büchner

Leuk Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.
Anna Hecht, Daniel Nowak, Verena Nowak, Benjamin Hanfstein, Andreas Faldum

Ann Hematol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival.
Florian Nolte, Anna Hecht, Mark Reinwald, Daniel Nowak, Verena Nowak

Leuk Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3.
Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, Maximilian Mossner, Florian Nolte, Anna Hecht

Genes Chromosomes Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
Michael Seilmaier, Anna Hecht, Wolfgang Guggemos, Klaus Rüdisser

Med Klin (Munich)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis